Reply to “Usefulness of Plasma Amyloid as Prescreener of the Earliest Alzheimer Pathological Changes Depends on the Study Population”

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
Pages (from-to)155
Number of pages1
JournalAnnals of Neurology
Issue number1
Early online date1 Nov 2019
Publication statusPublished - 1 Jan 2020

Cite this